カテゴリ： 世界, 医療/バイオ, Market Monitor Global

タンパク質阻害剤のグローバル市場展望 2023年-2029年：プロテインキナーゼ阻害剤、モノクローナル抗体、その他

■ 英語タイトル：Protein Inhibitors Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8613）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8613
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[タンパク質阻害剤のグローバル市場展望 2023年-2029年：プロテインキナーゼ阻害剤、モノクローナル抗体、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のタンパク質阻害剤市場規模と予測を収録しています。・世界のタンパク質阻害剤市場：売上、2018年-2023年、2024年-2029年
・世界のタンパク質阻害剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のタンパク質阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プロテインキナーゼ阻害剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

タンパク質阻害剤のグローバル主要企業は、Bayer AG、 Astra Zeneca、 Roche、 Teva、 Apotex、 Novartis、 Glaxosmithkline、 Pfizer、 Boehringer Ingelheim、 F. Hoffmann-La Roche、 Abbott Laboratories、 Amgen Inc.、 Baxter International Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、タンパク質阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のタンパク質阻害剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のタンパク質阻害剤市場：タイプ別市場シェア、2022年
・プロテインキナーゼ阻害剤、モノクローナル抗体、その他

世界のタンパク質阻害剤市場：用途別、2018年-2023年、2024年-2029年
世界のタンパク質阻害剤市場：用途別市場シェア、2022年
・腫瘍、炎症性疾患、その他

世界のタンパク質阻害剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のタンパク質阻害剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるタンパク質阻害剤のグローバル売上、2018年-2023年
・主要企業におけるタンパク質阻害剤のグローバル売上シェア、2022年
・主要企業におけるタンパク質阻害剤のグローバル販売量、2018年-2023年
・主要企業におけるタンパク質阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bayer AG、 Astra Zeneca、 Roche、 Teva、 Apotex、 Novartis、 Glaxosmithkline、 Pfizer、 Boehringer Ingelheim、 F. Hoffmann-La Roche、 Abbott Laboratories、 Amgen Inc.、 Baxter International Inc.

*************************************************************

・調査・分析レポートの概要
タンパク質阻害剤市場の定義
市場セグメント
世界のタンパク質阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のタンパク質阻害剤市場規模
世界のタンパク質阻害剤市場規模：2022年 VS 2029年
世界のタンパク質阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのタンパク質阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のタンパク質阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：プロテインキナーゼ阻害剤、モノクローナル抗体、その他
タンパク質阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：腫瘍、炎症性疾患、その他
タンパク質阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別タンパク質阻害剤市場規模 2022年と2029年
地域別タンパク質阻害剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer AG、 Astra Zeneca、 Roche、 Teva、 Apotex、 Novartis、 Glaxosmithkline、 Pfizer、 Boehringer Ingelheim、 F. Hoffmann-La Roche、 Abbott Laboratories、 Amgen Inc.、 Baxter International Inc.
...

This report aims to provide a comprehensive presentation of the global market for Protein Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Inhibitors. This report contains market size and forecasts of Protein Inhibitors in global, including the following market information:
Global Protein Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Protein Inhibitors Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Protein Inhibitors companies in 2022 (%)
The global Protein Inhibitors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Protein Kinase Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Protein Inhibitors include Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, Glaxosmithkline, Pfizer and Boehringer Ingelheim, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Protein Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Protein Inhibitors Market Segment Percentages, by Type, 2022 (%)
Protein Kinase Inhibitors
Monoclonal Antibody
Others
Global Protein Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Protein Inhibitors Market Segment Percentages, by Application, 2022 (%)
Oncology
Inflamatory Diseases
Others
Global Protein Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Protein Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein Inhibitors revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Protein Inhibitors revenues share in global market, 2022 (%)
Key companies Protein Inhibitors sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Protein Inhibitors sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Astra Zeneca
Roche
Teva
Apotex
Novartis
Glaxosmithkline
Pfizer
Boehringer Ingelheim
F. Hoffmann-La Roche
Abbott Laboratories
Amgen Inc.
Baxter International Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein Inhibitors, market overview.
Chapter 2: Global Protein Inhibitors market size in revenue and volume.
Chapter 3: Detailed analysis of Protein Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Protein Inhibitors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Protein Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Protein Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Protein Inhibitors Overall Market Size
2.1 Global Protein Inhibitors Market Size: 2022 VS 2029
2.2 Global Protein Inhibitors Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Protein Inhibitors Sales: 2018-2029
3 Company Landscape
3.1 Top Protein Inhibitors Players in Global Market
3.2 Top Global Protein Inhibitors Companies Ranked by Revenue
3.3 Global Protein Inhibitors Revenue by Companies
3.4 Global Protein Inhibitors Sales by Companies
3.5 Global Protein Inhibitors Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Protein Inhibitors Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Protein Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Protein Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Protein Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Protein Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Protein Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Protein Kinase Inhibitors
4.1.3 Monoclonal Antibody
4.1.4 Others
4.2 By Type – Global Protein Inhibitors Revenue & Forecasts
4.2.1 By Type – Global Protein Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global Protein Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global Protein Inhibitors Revenue Market Share, 2018-2029
4.3 By Type – Global Protein Inhibitors Sales & Forecasts
4.3.1 By Type – Global Protein Inhibitors Sales, 2018-2023
4.3.2 By Type – Global Protein Inhibitors Sales, 2024-2029
4.3.3 By Type – Global Protein Inhibitors Sales Market Share, 2018-2029
4.4 By Type – Global Protein Inhibitors Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Protein Inhibitors Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Inflamatory Diseases
5.1.4 Others
5.2 By Application – Global Protein Inhibitors Revenue & Forecasts
5.2.1 By Application – Global Protein Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global Protein Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global Protein Inhibitors Revenue Market Share, 2018-2029
5.3 By Application – Global Protein Inhibitors Sales & Forecasts
5.3.1 By Application – Global Protein Inhibitors Sales, 2018-2023
5.3.2 By Application – Global Protein Inhibitors Sales, 2024-2029
5.3.3 By Application – Global Protein Inhibitors Sales Market Share, 2018-2029
5.4 By Application – Global Protein Inhibitors Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Protein Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global Protein Inhibitors Revenue & Forecasts
6.2.1 By Region – Global Protein Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global Protein Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global Protein Inhibitors Revenue Market Share, 2018-2029
6.3 By Region – Global Protein Inhibitors Sales & Forecasts
6.3.1 By Region – Global Protein Inhibitors Sales, 2018-2023
6.3.2 By Region – Global Protein Inhibitors Sales, 2024-2029
6.3.3 By Region – Global Protein Inhibitors Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Protein Inhibitors Revenue, 2018-2029
6.4.2 By Country – North America Protein Inhibitors Sales, 2018-2029
6.4.3 US Protein Inhibitors Market Size, 2018-2029
6.4.4 Canada Protein Inhibitors Market Size, 2018-2029
6.4.5 Mexico Protein Inhibitors Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Protein Inhibitors Revenue, 2018-2029
6.5.2 By Country – Europe Protein Inhibitors Sales, 2018-2029
6.5.3 Germany Protein Inhibitors Market Size, 2018-2029
6.5.4 France Protein Inhibitors Market Size, 2018-2029
6.5.5 U.K. Protein Inhibitors Market Size, 2018-2029
6.5.6 Italy Protein Inhibitors Market Size, 2018-2029
6.5.7 Russia Protein Inhibitors Market Size, 2018-2029
6.5.8 Nordic Countries Protein Inhibitors Market Size, 2018-2029
6.5.9 Benelux Protein Inhibitors Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Protein Inhibitors Revenue, 2018-2029
6.6.2 By Region – Asia Protein Inhibitors Sales, 2018-2029
6.6.3 China Protein Inhibitors Market Size, 2018-2029
6.6.4 Japan Protein Inhibitors Market Size, 2018-2029
6.6.5 South Korea Protein Inhibitors Market Size, 2018-2029
6.6.6 Southeast Asia Protein Inhibitors Market Size, 2018-2029
6.6.7 India Protein Inhibitors Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Protein Inhibitors Revenue, 2018-2029
6.7.2 By Country – South America Protein Inhibitors Sales, 2018-2029
6.7.3 Brazil Protein Inhibitors Market Size, 2018-2029
6.7.4 Argentina Protein Inhibitors Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Protein Inhibitors Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Protein Inhibitors Sales, 2018-2029
6.8.3 Turkey Protein Inhibitors Market Size, 2018-2029
6.8.4 Israel Protein Inhibitors Market Size, 2018-2029
6.8.5 Saudi Arabia Protein Inhibitors Market Size, 2018-2029
6.8.6 UAE Protein Inhibitors Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Protein Inhibitors Major Product Offerings
7.1.4 Bayer AG Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Astra Zeneca
7.2.1 Astra Zeneca Company Summary
7.2.2 Astra Zeneca Business Overview
7.2.3 Astra Zeneca Protein Inhibitors Major Product Offerings
7.2.4 Astra Zeneca Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.2.5 Astra Zeneca Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Protein Inhibitors Major Product Offerings
7.3.4 Roche Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Teva
7.4.1 Teva Company Summary
7.4.2 Teva Business Overview
7.4.3 Teva Protein Inhibitors Major Product Offerings
7.4.4 Teva Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.4.5 Teva Key News & Latest Developments
7.5 Apotex
7.5.1 Apotex Company Summary
7.5.2 Apotex Business Overview
7.5.3 Apotex Protein Inhibitors Major Product Offerings
7.5.4 Apotex Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.5.5 Apotex Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Protein Inhibitors Major Product Offerings
7.6.4 Novartis Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Glaxosmithkline
7.7.1 Glaxosmithkline Company Summary
7.7.2 Glaxosmithkline Business Overview
7.7.3 Glaxosmithkline Protein Inhibitors Major Product Offerings
7.7.4 Glaxosmithkline Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.7.5 Glaxosmithkline Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Protein Inhibitors Major Product Offerings
7.8.4 Pfizer Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Protein Inhibitors Major Product Offerings
7.9.4 Boehringer Ingelheim Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Company Summary
7.10.2 F. Hoffmann-La Roche Business Overview
7.10.3 F. Hoffmann-La Roche Protein Inhibitors Major Product Offerings
7.10.4 F. Hoffmann-La Roche Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.10.5 F. Hoffmann-La Roche Key News & Latest Developments
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Company Summary
7.11.2 Abbott Laboratories Protein Inhibitors Business Overview
7.11.3 Abbott Laboratories Protein Inhibitors Major Product Offerings
7.11.4 Abbott Laboratories Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.11.5 Abbott Laboratories Key News & Latest Developments
7.12 Amgen Inc.
7.12.1 Amgen Inc. Company Summary
7.12.2 Amgen Inc. Protein Inhibitors Business Overview
7.12.3 Amgen Inc. Protein Inhibitors Major Product Offerings
7.12.4 Amgen Inc. Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.12.5 Amgen Inc. Key News & Latest Developments
7.13 Baxter International Inc.
7.13.1 Baxter International Inc. Company Summary
7.13.2 Baxter International Inc. Protein Inhibitors Business Overview
7.13.3 Baxter International Inc. Protein Inhibitors Major Product Offerings
7.13.4 Baxter International Inc. Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.13.5 Baxter International Inc. Key News & Latest Developments
8 Global Protein Inhibitors Production Capacity, Analysis
8.1 Global Protein Inhibitors Production Capacity, 2018-2029
8.2 Protein Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Protein Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Protein Inhibitors Supply Chain Analysis
10.1 Protein Inhibitors Industry Value Chain
10.2 Protein Inhibitors Upstream Market
10.3 Protein Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Protein Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • タンパク質ナノ粒子標識試薬のグローバル市場展望 2023年-2029年：酵素、モノクローナル抗体、プローブ/タグ、タンパク質、その他
  • 標的癌治療のグローバル市場展望 2023年-2029年：キナーゼ阻害剤、モノクローナル抗体、PARP阻害剤、その他
  • 腎臓がん治療薬のグローバル市場展望 2023年-2029年：血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2）
  • 抗VEGT薬のグローバル市場展望 2023年-2029年：チロシンキナーゼ阻害剤、モノクローナル抗体、その他
  • VDAC1抗体のグローバル市場展望 2023年-2029年：モノクローナル抗体、ポリクローナル抗体
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8613 )"タンパク質阻害剤のグローバル市場展望 2023年-2029年：プロテインキナーゼ阻害剤、モノクローナル抗体、その他" (英文：Protein Inhibitors Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。